相似文献
1
Echocardiography and renin-aldosterone interplay as predictors of death in COVID-19.
Arch Cardiovasc Dis. 2022 Feb;115(2):96-105. doi: 10.1016/j.acvd.2021.11.006. Epub 2022 Feb 2.
2
The elderly at risk: aldosterone as modulator of the immune response to SARS-CoV-2 infection.
Geroscience. 2022 Apr;44(2):567-572. doi: 10.1007/s11357-021-00481-4. Epub 2021 Nov 5.
3
[Role of age, comorbidity and renin- angiotensin-aldosterone system in COVID-19. Effects of ACE inhibitors and angiotensin receptor blockers].
Kardiologiia. 2020 Apr 8;60(4):4-9. doi: 10.18087/cardio.2020.4.n1122.
4
Renin-angiotensin-aldosterone inhibitors and COVID-19: nearing the end of a media-fuelled controversy.
Eur J Heart Fail. 2021 Mar;23(3):486-488. doi: 10.1002/ejhf.2098. Epub 2021 Jan 25.
5
Activation of the renin-angiotensin-aldosterone system is associated with Acute Kidney Injury in COVID-19.
Anaesth Crit Care Pain Med. 2020 Aug;39(4):453-455. doi: 10.1016/j.accpm.2020.06.006. Epub 2020 Jun 18.
6
Serum ACE2, Angiotensin II, and Aldosterone Levels Are Unchanged in Patients With COVID-19.
Am J Hypertens. 2021 Apr 2;34(3):278-281. doi: 10.1093/ajh/hpaa169.
7
Impact of renin-angiotensin-aldosterone system inhibitor continuation on outcomes for patients with severe coronavirus disease 2019 manifestations.
J Hypertens. 2021 Aug 1;39(8):1725-1726. doi: 10.1097/HJH.0000000000002876.
8
The Interplay Between the Immune System, the Renin-Angiotensin-Aldosterone System (RAAS), and RAAS Inhibitors May Modulate the Outcome of COVID-19: A Systematic Review.
J Clin Pharmacol. 2021 Aug;61(8):987-1000. doi: 10.1002/jcph.1852. Epub 2021 Apr 7.
9
COVID-19 and the Renin-Angiotensin-Aldosterone System.
Clin Infect Dis. 2021 Mar 15;72(6):1105-1107. doi: 10.1093/cid/ciaa818.
10
Renin-angiotensin system blockers and COVID-19.
BMC Med. 2021 Jun 4;19(1):136. doi: 10.1186/s12916-021-02012-6.
引用本文的文献
1
Literature Review-Transthoracic Echocardiography, Computed Tomography Angiography, and Their Value in Clinical Decision Making and Outcome Predictions in Patients with COVID-19 Associated Cardiovascular Complications.
Int J Environ Res Public Health. 2023 Jun 14;20(12):6123. doi: 10.3390/ijerph20126123.
本文引用的文献
1
COVID-19 and Cardiovascular Disease: From Bench to Bedside.
Circ Res. 2021 Apr 16;128(8):1214-1236. doi: 10.1161/CIRCRESAHA.121.317997. Epub 2021 Apr 15.
2
Cardiac Injury in COVID-19-Echoing Prognostication.
J Am Coll Cardiol. 2020 Nov 3;76(18):2056-2059. doi: 10.1016/j.jacc.2020.08.068.
3
Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19.
N Engl J Med. 2020 Jun 18;382(25):2431-2440. doi: 10.1056/NEJMoa2006923. Epub 2020 May 1.
4
Complex Association of Sex Hormones on Left Ventricular Systolic Function: Insight into Sexual Dimorphism.
J Am Soc Echocardiogr. 2018 Feb;31(2):231-240.e1. doi: 10.1016/j.echo.2017.10.017. Epub 2017 Dec 13.
5
Impact of negative inotropic drugs on accuracy of diastolic stress echocardiography for evaluation of left ventricular filling pressure.
Sci Rep. 2017 Aug 25;7(1):9537. doi: 10.1038/s41598-017-10301-5.
6
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.
J Am Soc Echocardiogr. 2016 Apr;29(4):277-314. doi: 10.1016/j.echo.2016.01.011.
7
Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.
J Am Soc Echocardiogr. 2015 Jan;28(1):1-39.e14. doi: 10.1016/j.echo.2014.10.003.
Zotero 插件